161 related articles for article (PubMed ID: 38463575)
1. Clinical analysis of hairy cell leukemia: the rare indolent hematological malignancy.
Huang H; Liu Y; Zeng M; Chen X; Yin Y; Guo H; Yan Z; Lin J
Am J Transl Res; 2024; 16(2):466-476. PubMed ID: 38463575
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
[No Abstract] [Full Text] [Related]
3. [Clinical analysis of 24 patients of hairy cell leukemia treated by cladribine].
Wang TY; Li ZJ; Lyu R; Fu MW; Sui WW; Huang WY; Liu W; An G; Deng SH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):491-495. PubMed ID: 30032567
[No Abstract] [Full Text] [Related]
4. Hairy cell leukemia: A retrospective study on 11 patients in the Western of Iran.
Payandeh M; Sadeghi M; Sadeghi E
Int J Hematol Oncol Stem Cell Res; 2015 Jul; 9(3):133-7. PubMed ID: 26261698
[TBL] [Abstract][Full Text] [Related]
5. [Hairy cell leukemia and pregnancy].
Al-Radi LS; Moiseeva TN; Smirnova SY; Shmakov RG
Ter Arkh; 2017; 89(7):99-104. PubMed ID: 28766548
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of BRAF
Smirnova SY; Al-Radi LS; Moiseeva TN; Gemdzhian EG; Yakutik IA; Julhakyan HL; Novikov VA; Galstyan GM; Sudarikov AB
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):427-430. PubMed ID: 33811006
[TBL] [Abstract][Full Text] [Related]
7. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB
Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with splenectomy and cladribine in hairy cell leukemia in Taiwan: a clinicopathologic study of 5 cases.
Yu YB; Li CY; Chen CC; You JY; Chau WK; Hsu HC; Gau JP; Chen PM; Ho CH
J Chin Med Assoc; 2007 Dec; 70(12):551-5. PubMed ID: 18194897
[TBL] [Abstract][Full Text] [Related]
9. Treatment Outcomes Of Patients With Hairy Cell Leukaemia; A 16-Year Experience At A Tertiary Care Center In Pakistan.
Yousaf M; Khan MA; Iftikhar R; Chaudary QU; Shahbaz N; Ahmad U; Javed H
J Ayub Med Coll Abbottabad; 2022; 34(4):797-801. PubMed ID: 36566402
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hairy cell leukemia-variant with cladribine.
Tetreault SA; Robbins BA; Saven A
Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
[TBL] [Abstract][Full Text] [Related]
11. Clinical analysis of prolymphoblastic leukemia: the rare hematological malignancy in the elderly.
Yan Z; Zeng M; Chen X; Yin Y; Liu Y
Am J Transl Res; 2023; 15(9):5653-5663. PubMed ID: 37854229
[TBL] [Abstract][Full Text] [Related]
12. Atraumatic Splenic Rupture as an Unusual Presentation of Hairy Cell Leukemia: A Case Report.
Proskuriakova E; Sakhuja A; Khan S; Shrestha DB; Khosla P
Cureus; 2023 Jun; 15(6):e40180. PubMed ID: 37431331
[TBL] [Abstract][Full Text] [Related]
13. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.
Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X;
Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538
[TBL] [Abstract][Full Text] [Related]
14. Untangling the Strands of Hairy Cell Leukemia: The Clinicopathological Spectrum over Eleven Years at a Tertiary Care Center.
Rai V; Manimaran P; Saha A; Kailashiya V; Sawhney J; Ramawat S; Kakoty S
Discoveries (Craiova); 2023; 11(2):e166. PubMed ID: 37538441
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of hairy cell leukemia over a period of 20 years.
Wiber M; Maitre E; Poncet JM; Duchenet V; Damaj G; Cornet E; Troussard X
Cancer Treat Res Commun; 2020; 25():100236. PubMed ID: 33227559
[TBL] [Abstract][Full Text] [Related]
16. My treatment approach to hairy cell leukemia.
Naik RR; Saven A
Mayo Clin Proc; 2012 Jan; 87(1):67-76. PubMed ID: 22212971
[TBL] [Abstract][Full Text] [Related]
17. Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib.
Paillassa J; Safa F; Troussard X
Ther Adv Hematol; 2022; 13():20406207221090886. PubMed ID: 35450208
[TBL] [Abstract][Full Text] [Related]
18. Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.
Maitre E; Tomowiak C; Lebecque B; Bijou F; Benabed K; Naguib D; Kerneves P; Cornet E; Viailly PJ; Arsham J; Sola B; Jardin F; Troussard X
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454811
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study.
Pagano L; Criscuolo M; Broccoli A; Piciocchi A; Varettoni M; Galli E; Anastasia A; Cantonetti M; Trentin L; Kovalchuk S; Orsucci L; Frustaci A; Spolzino A; Volpetti S; Annibali O; Storti S; Stelitano C; Marchesi F; Offidani M; Casadei B; Nizzoli ME; De Luca ML; Fianchi L; Motta M; Guarnera L; Simonetti E; Visentin A; Vassallo F; Deodato M; Sarlo C; Olivieri A; Falini B; Pulsoni A; Tiacci E; Zinzani PL
Blood Cancer J; 2022 Jul; 12(7):109. PubMed ID: 35853850
[TBL] [Abstract][Full Text] [Related]
20. [Hairy cell leukemia complicated by bone marrow necrosis following cladribine administration].
Terao T; Yuda J; Yamauchi N; Miyamoto K; Minami M; Kojima M; Sugano M; Kuwata T; Minami Y
Rinsho Ketsueki; 2019; 60(6):559-564. PubMed ID: 31281144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
